Ibex Was Selected Among the First Ever Winners of the AI in Health and Care Award, Sharing £50 Million to Enable a Study of Ibex’s AI Technology…

LDPath will deploy Ibex’s Galen Prostate, an AI-powered solution to support pathologists in enhancing diagnostic accuracy and efficiency Ibex Medical…

Developed by Lunit, the company specializing in medical AI, the software detects breast cancer with an accuracy of 97% A study published in…

Ibex's Galen Prostate Solution Demonstrates Outstanding Results in a Blinded Study and Supports Pathologists in Providing Accurate Diagnosis, Enhanced…

Machine learning will now tell pathologists, that’s cancer, and that’s not cancer. Google’s AI research lab is bringing new technologies at the core…

iFlytek, the largest publicly-listed AI technology company in the Asia-Pacificregion has further advanced its healthcare initiative by leading…

Ezra's Prostate AI is the first to ever by cleared by the FDA Ezra, the NY-based startup transforming early cancer screening using MRI, announced…

Positive data show high sensitivity and specificity in the detection of Lymphoma and Hemangiosarcoma as Volition remains on target for launch of its…

Using AI and Augmented Reality, Google Cloud Will Help Improve Patient Outcomes and Reduce Cost Google Cloud announced that the Defense Innovation…

Volparaplatform Optimizes and Personalizes Patient Screening Pathways Volpara Solutions will spotlight the VolparaPlatform, a comprehensive suite…